NA
TECH icon

NewEdge Advisors’s Bio-Techne TECH Stock Holding History

NewEdge Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705K Buy
9,972
+2,247
+29% +$121K ﹤0.01% 1905
2026
Q1 		$404K Buy
7,725
+7,677
+15,994% +$461K ﹤0.01% 2143
2025
Q4 		$2.82K Sell
48
-4
-8% -$243 ﹤0.01% 3816
2025
Q3 		$2.89K Hold
52
– – ﹤0.01% 3691
2025
Q2 		$2.68K Hold
52
– – ﹤0.01% 3564
2025
Q1 		$3.05K Hold
52
– – ﹤0.01% 3417
2024
Q4 		$3.75K Sell
52
-21
-29% -$1.54K ﹤0.01% 3309
2024
Q3 		$5.84K Sell
73
-8
-10% -$601 ﹤0.01% 3119
2024
Q2 		$5.81K Sell
81
-5
-6% -$368 ﹤0.01% 3045
2024
Q1 		$6.06K Buy
86
+10
+13% +$716 ﹤0.01% 3070
2023
Q4 		$5.87K Buy
76
+56
+280% +$3.69K ﹤0.01% 3070
2023
Q3 		$1.36K Sell
20
-6
-23% -$474 ﹤0.01% 3123
2023
Q2 		$2.12K Buy
26
+6
+30% +$482 ﹤0.01% 3075
2023
Q1 		$1.49K Sell
20
-356
-95% -$27.4K ﹤0.01% 3094
2022
Q4 		$29.5K Buy
+376
New +$29.9K ﹤0.01% 1970
2021
Q4 		– Sell
-4,868
Closed -$590K – 1696
2021
Q3 		$590K Buy
+4,868
New +$592K 0.01% 705

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NewEdge Advisors's TECH Position: Q2 2026 in Review

NewEdge Advisors increased its Bio-Techne (TECH) stake by 29% in Q2 2026, buying an estimated $121K and bringing the position to 9,972 shares worth $705K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

NewEdge Advisors first reported a position in TECH in Q3 2021 and has held it in 16 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • NewEdge Advisors held 9,972 shares of Bio-Techne worth $705K as of Q2 2026.
  • NewEdge Advisors bought 2,247 Bio-Techne shares in Q2 2026, an estimated $121K.
  • Bio-Techne made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1905 holding.
  • NewEdge Advisors first reported a position in Bio-Techne in Q3 2021 and has held it in 16 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.